Endo to Acquire Qualitest and Expand its Generics Portfolio

By Heather Cartwright

Pharma Deals Review: Vol 2010 Issue 8 (Table of Contents)

Published: 27 Oct-2010

DOI: 10.3833/pdr.v2010.i8.1394     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Qualitest Pharmaceuticals, the sixth largest generics company in the US as measured by prescriptions filled, is being acquired by Endo Pharmaceuticals in a cash deal worth US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details